
Mesenchymal stromal cells in myeloid malignancies: …
2024年2月15日 · Mesenchymal stromal cells (MSCs) residing in the bone marrow exert immunosuppressive functions by suppressing innate and adaptive immune systems, thus creating a supportive and tolerant microenvironment for myeloid malignancy progression.
MMP14 from BM-MSCs facilitates progression and Ara-C …
9 小时之前 · Growing evidence underscores the pivotal impact of crosstalk between leukemic stem cells (LSCs) and mesenchymal stromal cells (MSCs) within their niche on leukemia initiation, progression, and therapy response. Although MMP14 plays an important role in inflammation and cancer, the regulation and role of MSC-derived MMP14 in acute myeloid leukemia (AML) are largely unknown.
Acute myeloid leukemia (AML)‐derived mesenchymal stem cells …
Mesenchymal stem cells (MSCs) in the leukemia microenvironment contribute to chemoresistance in AML, but the specific mechanism remains unclear. The critical role of the epithelial–mesenchymal transition (EMT)‐like profile in AML …
Mesenchymal stromal cells derived from acute myeloid leukemia …
2015年4月10日 · Bone marrow-derived mesenchymal stromal cells (BM-MSCs) play a fundamental role in the BM microenvironment (BME) and abnormalities of these cells may contribute to acute...
Bone marrow mesenchymal stromal cells from acute myelogenous leukemia …
2019年9月6日 · In this work, we compared normal donor (ND) and acute myelogenous leukemia (AML) derived MSCs and found that AML-MSCs had increased adipogenic potential with improved ability to support...
Mesenchymal stromal cells from myelodysplastic and acute …
2018年10月25日 · Mesenchymal stromal cells (MSCs) are an essential element of the bone marrow (BM) microenvironment, playing a crucial function in regulating hematopoietic stem cell proliferation and differentiation. Recent findings have outlined a putative role for MSCs in hematological malignancy development.
MSCs induced by AML bone marrow prompt chemotherapy …
2024年4月1日 · The MSCs induced by AML bone marrow could increase the chemotherapy drug resistance of PBMNCs in bone marrow micro-environment through TPO-C-MPL pathway. Its mechanism was mainly related with prompting the expression of TPO and c-MPL factors, indicating that TPO-C-MPL might be adopted as the therapeutic target of AML treatment.
LncRNA SNHG5 induces CAFs-like phenotype and autophagy of AML-MSCs …
AML cells-derived exosomes delivered SNHG5 to enhance its expression in MSCs. SNHG5 overexpression induced CAFs-like phenotype and autophagy in MSCs that led to daunorubicin resistance of AML cells. Mechanistically, SNHG5 stabilized autophagy related 5 (ATG5) mRNA by interaction with polypyrimidine tract-binding protein 1 (PTBP1).
Exosome‐Shuttled METTL14 From AML‐Derived Mesenchymal …
2024年12月18日 · Acute myelogenous leukemia (AML)-derived mesenchymal stem cells (MSCs) (AML-MSCs) have been identified to play a significant role in AML progression. The functions of MSCs mainly depend on their paracrine action. Here, we investigated whether AML-MSCs functioned in AML cells by transferring METTL14 (Methyltransferase 14) into AML cells via ...
Exosome-Shuttled METTL14 From AML-Derived Mesenchymal …
Acute myelogenous leukemia (AML)-derived mesenchymal stem cells (MSCs) (AML-MSCs) have been identified to play a significant role in AML progression. The functions of MSCs mainly depend on their paracrine action. Here, we investigated whether AML-MSCs functioned in AML cells by transferring METTL14 …
- 某些结果已被删除